This observational study is following people with depression or Treatment Resistant Depression to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
In United States
Why is this study shown?
This study is directly about Depression.
DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 25 Years to 70 Years
This study is comparing Psilocybin 25 mg with placebo for people with major depression. Participants receive Psilocybin 25 mg or placebo and complete study visits and assessments.
This study is completed in the United States. It is testing Performance Validity and Test-Retest Reliability of a Computer-Administered Cognitive Test Battery for depression.
This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand whether a therapy or guided support program can make support easier to access outside standard clinic visits.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.